Inflammatory bowel diseases have an impact on the prognosis of multiple sclerosis, according to a study published in PLOS One.
The brains of children and adolescents with attention deficit hyperactivity disorder (ADHD) are slower to develop some key connections, according to a study published in the Proceedings of the National Academy of Sciences.
Practices that are part of a parental tobacco control intervention have higher rates of delivering tobacco control assistance to parents over a one-year follow-up period, according to a study published online Oct. 20 in Pediatrics.
Dutch guidelines, implemented in 1999, do not appear to be effective for reducing the incidence of invasive group B streptococcal disease in newborns, according to a study published in the November issue of The Lancet Infectious Diseases.
A formal yoga program may be beneficial for pediatric patients newly diagnosed with inflammatory bowel disease, according to a study presented at the annual meeting of the American College of Gastroenterology, held from Oct. 17 to 22 in Philadelphia.
The US Food and Drug Administration (FDA) approved Genzyme’s application to include new information about its multiple sclerosis drug teriflunomide (Aubagio) on its label. The new labeling content is efficacy and safety data from two Phase III trials of the drug.
When it comes to preparing your medical practice for the upcoming flu season, the key to success if being proactive, not reactive. A proactive approach means a more efficient and productive practice.